Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Regulus Therapeutics Inc. buy HC Wainwright

Start price
€2.26
06.05.24 / 50%
Target price
€8.35
06.05.25
Performance (%)
-1.77%
Price
€2.26
20.06.24
Summary
This prediction is currently active. With a performance of -1.77%, the BUY prediction for Regulus Therapeutics Inc. by HC_Wainwright is down slightly. This prediction currently runs until 06.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Regulus Therapeutics Inc. 0.000% 0.000%
iShares Core DAX® 1.080% -2.933%
iShares Nasdaq 100 0.362% 7.015%
iShares Nikkei 225® -1.155% -1.155%
iShares S&P 500 0.806% 4.388%

Comments by HC_Wainwright for this prediction

In the thread Regulus Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -1.77%
Target price 8.351
Change
Ends at 06.05.25

Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat

Stopped prediction by HC_Wainwright for Regulus Therapeutics Inc.

buy
Regulus Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.64
25.03.24
€8.30
25.03.25
-15.91%
20.06.24

buy
Regulus Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.50
19.09.23
€8.41
19.09.24
50.67%
20.06.24